UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009244
Receipt number R000009394
Scientific Title Assessment of recurrence rate of radiofrequency ablation in the corona enhancement area.
Date of disclosure of the study information 2012/11/01
Last modified on 2019/05/14 09:39:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of recurrence rate of radiofrequency ablation in the corona enhancement area.

Acronym

Assessment of recurrence rate of radiofrequency ablation

Scientific Title

Assessment of recurrence rate of radiofrequency ablation in the corona enhancement area.

Scientific Title:Acronym

Assessment of recurrence rate of radiofrequency ablation

Region

Japan


Condition

Condition

hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the area of recurrence lesion after radio frequency ablation

Basic objectives2

Others

Basic objectives -Others

recurrence rate

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

recurrence rate

Key secondary outcomes

side effect


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

tumor diameter is more than 30 mm
tumor number is more than 3
number of platelet is more than 30000
PT is more than 50 %

Key exclusion criteria

extrahepatic metastasis
invasion of intrahepatic vessel

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoichi Hiasa

Organization

Ehime University

Division name

Gastroenterology and Metabology

Zip code


Address

Shizukawa 454, Ehimeken, Touon-shi, Japan

TEL

089-960-5308

Email

hiasa@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masashi Hirooka

Organization

Ehime University

Division name

Gastroenterology and Metabology

Zip code


Address

Shizukawa 454, Ehimeken, Touon-shi, Japan

TEL

+81-89-960-5308

Homepage URL


Email

masashih@m.ehime-u.ac.jp


Sponsor or person

Institute

Ehime University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 04 Month 23 Day

Date of IRB

2012 Year 04 Month 23 Day

Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2019 Year 05 Month 14 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2012 Year 11 Month 01 Day

Last modified on

2019 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009394


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name